Bobby Gaspar Orchard Therapeutics PLC (ORTX) insider trading activity

ORTX Quotes by TradingView

Bobby Gaspar is Chief Executive Officer of Orchard Therapeutics plc. Currently has a direct ownership of 0 shares of ORTX, which is worth approximately $0. The most recent transaction as insider was on Jan 24, 2024, when has been sold 366,158 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Bobby Gaspar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 24 2024
SELL
Sale (or disposition) back to the issuer
-
366,158 Reduced 100.0%
0 Ordinary Shares
Apr 01 2022
BUY
Open market or private purchase
$11,100 $0.74 p/Share
15,000 Added 3.94%
366,158 Ordinary Shares
Jan 11 2021
SELL
Payment of exercise price or tax liability
$22,922 $6.72 p/Share
3,411 Reduced 0.96%
351,158 Ordinary Shares
Jan 08 2021
BUY
Grant, award, or other acquisition
-
6,250 Added 1.73%
354,569 Ordinary Shares
BG

Bobby Gaspar

Chief Executive Officer
London, X0

Track Institutional and Insider Activities on ORTX

Follow Orchard Therapeutics plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORTX shares.

Notify only if

Insider Trading

Get notified when an Orchard Therapeutics PLC insider buys or sells ORTX shares.

Notify only if

News

Receive news related to Orchard Therapeutics plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ORTX